New European Commission Study To Review Experience With Human Drug Authorization Procedures
Executive Summary
The European Commission is deciding on the terms of reference of an external study, to be completed in 2018, in order to comply with its legal obligation of publishing a general report every 10 years on the experience acquired with various EU marketing authorization procedures for human drugs.